Requires the Comptroller General to assess and report on wearable medical devices' capabilities and limitations in clinical decision-making, focusing on AI's benefits and challenges, and proposing policy options to enhance benefits and mitigate challenges.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the risk subdomain are described.
All other risk subdomains had no coverage in this document.
Risk Coverage Summary
The document has minimal coverage of risk domains, primarily addressing AI system safety and limitations (7.3, 7.4) through its focus on assessing capabilities and limitations of wearable medical devices. There is implicit coverage of human-computer interaction risks (5.1) related to clinical decision-making reliance. The document is primarily a mandate for assessment rather than regulation of specific risks.
Good coverage — Comprehensive governance measures or mitigations with clear procedures relating to the sector are explicitly described.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the sector are described.
All other sectors had no coverage in this document.
Sectors Summary
The document primarily governs the Health Care and Social Assistance sector through its focus on wearable medical devices used in clinical decision-making. It also has implications for the Scientific Research and Development Services sector through the technology assessment mandate, and potentially the Information sector given the AI and data processing components of wearable medical devices.
Hard Law
Legislative Status Summary
This is a binding legislative provision enacted by the United States Congress that creates a mandatory reporting obligation on the Comptroller General with specific deadlines and requirements.
Proposer
Target
Enforcer
Monitor
Lifecycle stages covered by the documents, as defined in the OECD Framework for the Classification of AI Systems
AI Lifecycle Summary
The document addresses multiple AI lifecycle stages with primary focus on Verify and Validate (assessment of capabilities and limitations) and Operate and Monitor (examining devices used in clinical settings). It also implicitly covers Build and Use Model through examination of AI augmentation capabilities, and Plan and Design through policy options for development.
Terms relating to technical scope that are mentioned or implicitly referenced in the document
Technical Scope Summary
The document explicitly mentions artificial intelligence in the context of wearable medical devices but does not define or distinguish between AI models, AI systems, or specific types of AI. It focuses on AI's role in augmenting clinical decision-making capabilities without specifying technical architectures or compute thresholds.
Document data from AGORA, CSET Emerging Technology Observatory.